Evidence map›Paper›PMID 23922722›Full record

ArticlePloS one2013

MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line.

Jun Iwaki, Kunio Kikuchi, Yoshiaki Mizuguchi, Yutaka Kawahigashi, Hiroshi Yoshida, Eiji Uchida, Toshihiro Takizawa

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Molecular Targets and Signaling Pathways in Cholangiocarcinoma: A Systematic Review.Asian Pacific journal of cancer prevention : APJCP · 2023
    Pooled it
  2. Article
  3. Unique miRomics Expression Profiles inInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. MicroRNA-629-5p promotes osteosarcoma proliferation and migration by targeting caveolin 1.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Article
  6. Exosomal noncoding RNAs in cholangiocarcinoma: Laboratory noise or hope?World journal of gastrointestinal surgery · 2020
    Review
  7. Review
  8. Article
  9. Article
  10. Bioscience reports · 2018
    Article
  11. Article
  12. NcRNAs and Cholangiocarcinoma.Journal of Cancer · 2018
    Review
  13. Review
  14. Serum microRNA-376 family as diagnostic and prognostic markers in human gliomas.Cancer biomarkers : section A of Disease markers · 2017
    Article
  15. The role of microRNAs in intrahepatic cholangiocarcinoma.Journal of cellular and molecular medicine · 2017
    Review
  16. Review
  17. Review
  18. EGFR Signaling in Liver Diseases.International journal of molecular sciences · 2015
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jun IwakiDepartment of Molecular Medicine and Anatomy, Nippon Medical School, Tokyo, Japan.
Kunio Kikuchi
Yoshiaki Mizuguchi
Yutaka Kawahigashi
Hiroshi Yoshida
Eiji Uchida
Toshihiro Takizawa
Nippon Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNA miR-376c was expressed in normal intrahepatic biliary epithelial cells (HIBEpiC), but was significantly suppressed in the HuCCT1 intrahepatic cholangiocarcinoma (ICC) cell line. The biological significance of the down-regulation of miR-376c in HuCCT1 cells is unknown. We hypothesized that miR-376c could function as a tumor suppressor in these cells. To test this hypothesis, we sought the targets of miR-376c, and characterized the effect of its down-regulation on HuCCT1 cells. We performed proteomic analysis of miR-376c-overexpressing HuCCT1 cells to identify candidate targets of miR-376c, and validated these targets by 3'-UTR reporter assay. Transwell migration assays were performed to study the migratory response of HuCCT1 cells to miR-376c overexpression. Furthermore, microarrays were used to identify the signaling that were potentially involved in the miR-376c-modulated migration of HuCCT1. Finally, we assessed epigenetic changes within the potential promoter region of the miR-376c gene in these cells. Proteomic analysis and subsequent validation assays showed that growth factor receptor-bound protein 2 (GRB2) was a direct target of miR-376c. The transwell migration assay revealed that miR-376c significantly reduced epidermal growth factor (EGF)-dependent cell migration in HuCCT1 cells. DNA microarray and subsequent pathway analysis showed that interleukin 1 beta and matrix metallopeptidase 9 were possible participants in EGF-dependent migration of HuCCT1 cells. Bisulfite sequencing showed higher methylation levels of CpG sites upstream of the miR-376c gene in HuCCT1 relative to HIBEpiC cells. Combined treatment with the DNA-demethylating agent 5-aza-2'-deoxycytidine and the histone deacetylase inhibitor trichostatin A significantly upregulated the expression of miR-376c in HuCCT1 cells. We revealed that epigenetic repression of miR-376c accelerated EGF-dependent cell migration through its target GRB2 in HuCCT1 cells. These findings suggest that miR-376c functions as a tumor suppressor. Since metastasis is the major cause of death in ICC, microRNA manipulation could lead to the development of novel anti-cancer therapy strategies for ICC.

Indexed as

Bile Duct NeoplasmsBile Ducts, IntrahepaticCell Line, TumorCell MovementCholangiocarcinomaDNA MethylationDown-RegulationEpidermal Growth FactorEpigenesis, GeneticGene Expression Regulation, NeoplasticGene Regulatory NetworksGRB2 Adaptor ProteinHumansLiver NeoplasmsMicroRNAsNeoplasm ProteinsEpidermal Growth FactorGRB2 Adaptor ProteinGRB2 protein, humanMicroRNAsMIRN376C microRNA, humanNeoplasm Proteins

Identifiers

PMID23922722
PMCPMC3724868
OpenAlexW1992302449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.